Intco Medical Technology Co Ltd
SZSE:300677
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Intco Medical Technology Co Ltd
SZSE:300677
|
CN |
|
Rhoen Klinikum AG
XETRA:RHK
|
DE |
|
Aluula Composites Inc
XTSX:AUUA
|
CA |
|
Parkmead Group PLC
LSE:PMG
|
UK |
|
GlaxoSmithKline Pharmaceuticals Ltd
NSE:GLAXO
|
IN |
|
Capital Ltd
LSE:CAPD
|
MU |
|
A
|
Anhui Huaren Health Pharmaceutical Co Ltd
SZSE:301408
|
CN |
|
Ensign Group Inc
NASDAQ:ENSG
|
US |
|
C
|
China Railway Special Cargo Logistics Co Ltd
SZSE:001213
|
CN |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Intco Medical Technology Co Ltd's stock price target?
Not Available
Intco Medical Technology Co Ltd doesn't have any price targets made by Wall Street professionals.
What is Intco Medical Technology Co Ltd's Revenue forecast?
Projected CAGR
13%
For the last 9 years the
compound annual growth rate for
Intco Medical Technology Co Ltd's revenue is
28%.
The projected
CAGR
for the next 3 years is
13%.
What is Intco Medical Technology Co Ltd's Operating Income forecast?
Projected CAGR
24%
For the last 9 years the
compound annual growth rate for
Intco Medical Technology Co Ltd's operating income is
30%.
The projected
CAGR
for the next 3 years is
24%.
What is Intco Medical Technology Co Ltd's Net Income forecast?
Projected CAGR
12%
For the last 9 years the
compound annual growth rate for
Intco Medical Technology Co Ltd's net income is
42%.
The projected
CAGR
for the next 3 years is
12%.
